Stomach Cancer Trial, Recruiting NCT07307560 Sponsor: Zhejiang University Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT07307560
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who score 5 or higher on the STOP-Bang questionnaire, which is a screening tool used to assess the likelihood of sleep apnea
  • People who are already scheduled to have a sedated gastrointestinal endoscopy procedure (such as a gastroscopy, colonoscopy, or both together)
  • People whose procedure is expected to take no longer than 45 minutes
  • People who have signed the trial's informed consent form

Who may not be able to join:

  • People with blood clotting disorders or a tendency to bleed (confirm with trial site)
  • People with an active infection of the mouth, nose, or throat, or who have a fever above 37.5°C
  • People with chronic obstructive pulmonary disease (COPD) or other lung conditions that require regular or occasional oxygen therapy, or whose blood oxygen level is at or below 92% while breathing normal room air
  • People with serious organ problems, including poor heart function, kidney failure requiring dialysis, severe liver disease, raised pressure in the skull, or those classified as having very poor overall physical health under standard medical assessment (ASA status IV or higher)
  • People who are pregnant or currently breastfeeding
  • People with a known allergy to sedative medications (such as propofol) or to medical adhesive products
  • People who have sustained multiple traumatic injuries
  • People who are currently taking part in another clinical trial
  • People considered unsuitable by the trial investigators for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8618616514088

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zhejiang University
Registry
ClinicalTrials.gov
Start date
21 December 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The incidence of hypoxia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov